These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2652545)

  • 1. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
    Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
    Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
    Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function.
    Adams MB; Johnson CP; Roza AM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1606-8. PubMed ID: 2652523
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors.
    Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of donor specific transfusion and cyclosporine A on graft outcome.
    Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506
    [No Abstract]   [Full Text] [Related]  

  • 9. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
    Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
    [No Abstract]   [Full Text] [Related]  

  • 10. Donor-specific blood transfusions versus cyclosporine--the DST story.
    Salvatierra O; Melzer J; Vincenti F; Amend WJ; Tomlanovich S; Potter D; Husing R; Garovoy M; Feduska NJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):160-6. PubMed ID: 3547813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 13. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.
    Griñó JM; Bas J; Gonzalez C; Castelao AM; Seron D; Mestre M; Buendia E; Sabate R; Diaz C; Alsina J
    Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac transplantation in the sixth decade of life.
    Szentpetery S; Thames M; Hanrahan J; Morris J; Lower RR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved results of renal transplantation in diabetic nephropathy.
    Wilczek H; Gunnarsson R; Lundgren G; Ost L
    Transplant Proc; 1984 Jun; 16(3):623-7. PubMed ID: 6375029
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of cyclosporine, donor-specific transfusion, and antilymphocyte serum suppression of skin, heart, and fetal pancreatic islet allograft rejection in mice.
    Mason A; Mottram PL; Mirisklavos A; Clurne GJ; Mandel TE
    Transplantation; 1988 Jun; 45(6):1155-7. PubMed ID: 3132766
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor specific blood transfusions do not improve graft survival in living related donor transplantation.
    Garcia VD; Kraemer ES; Prompt CA; Santos A; Caovila J; Duarte A; Filho AN; Goldani JC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2271-3. PubMed ID: 3274507
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine.
    Veremis SA; Maddux MS; Pollak R; Kline SS; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.